Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
X Bioscience PCLBKK:XBIO Current Ratio is 0.97 as of Mar. 2026, which is 5% below its 10-year median of 1.02. The stock has 6 warning signs investors should review. Among 363 Restaurants companies, X Bioscience PCL ranks worse than 51.79% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. X Bioscience PCL's current ratio for the quarter that ended in Mar. 2026 was 0.97.
X Bioscience PCL has a current ratio of 0.97. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If X Bioscience PCL has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for X Bioscience PCL's Current Ratio or its related term are showing as below:
BKK:XBIO'
s Current Ratio Range Over the Past 10 Years
Min: 0.08 Med: 1.02 Max: 33.54
Current: 0.97
During the past 13 years, X Bioscience PCL's highest Current Ratio was 33.54. The lowest was 0.08. And the median was 1.02.
BKK:XBIO's Current Ratio is ranked worse than 51.79% of 363
companies
in the Restaurants industry
Industry Median: 1.01
vs BKK:XBIO: 0.97
X Bioscience PCL (BKK:XBIO) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
X Bioscience PCL Current Ratio Related Terms
X Bioscience PCL Current Ratio Historical Data
* Premium members only.
The historical data trend for X Bioscience PCL's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:XBIO vs SYY, USFD, PFGC: Current Ratio Comparison
For the Restaurants subindustry, X Bioscience PCL's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
X Bioscience PCL Current Ratio vs Restaurants Industry
For the Restaurants industry and Consumer Cyclical sector, X Bioscience PCL's Current Ratio distribution charts can be found below:
* The bar in red indicates where X Bioscience PCL's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
X Bioscience PCL (BKK:XBIO) has a Current Ratio of 0.97 as of Mar. 2026. This is near median its historical median of 1.02. Over the past decade, X Bioscience PCL's Current Ratio has ranged from 0.08 to 33.54. According to the industry distribution chart, X Bioscience PCL ranks #188 out of 363 companies in the Restaurants industry, placing it in the top 51.8%.
Is X Bioscience PCL's Current Ratio too high?
X Bioscience PCL's current Current Ratio of 0.97 is near median its 10-year median of 1.02. Over the past 10 years, this metric has ranged from a low of 0.08 to a high of 33.54. The Restaurants industry median Current Ratio is 1.01. X Bioscience PCL's value of 0.97 is 4% below this industry median. Based on the distribution chart, X Bioscience PCL ranks #188 out of 363 companies in the Restaurants industry, which is below the industry midpoint.
How does X Bioscience PCL's Current Ratio compare to SYY and USFD?
According to the Restaurants industry distribution chart, X Bioscience PCL ranks #188 out of 363 companies for Current Ratio. This places X Bioscience PCL in the lower half of its industry. The industry median Current Ratio is 1.01. X Bioscience PCL's value of 0.97 is 4% below this benchmark. Historically, X Bioscience PCL's own Current Ratio has ranged from 0.08 to 33.54 over the past decade. While the company's 10-year median is 1.02 vs. the industry median of 1.01, X Bioscience PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Restaurants company?
The median Current Ratio among Restaurants companies is 1.01, based on 363 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. X Bioscience PCL's current Current Ratio of 0.97 is 4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Restaurants industry, the median Current Ratio is 1.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. X Bioscience PCL's current Current Ratio is 0.97, which is near median its own 10-year median of 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is X Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, X Bioscience PCL (BKK:XBIO) is currently considered Possible Value Trap. The stock's GF Value™ is ฿0.10, compared to a current price of ฿0.07 — trading 30% below its estimated fair value. The current Current Ratio is 0.97, which is near median its 10-year median of 1.02 and 4% below the Restaurants industry median of 1.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For X Bioscience PCL (BKK:XBIO), the current Current Ratio is 0.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
X Bioscience PCL, along with its subsidiaries, is mainly engaged in selling food and beverages by operating restaurants and bakery shops under the Le Boeuf, Kagonoya, Bake Cheese Tart, Croquant Chou ZakuZaku, and RAPL trademarks. Additionally, the Group is involved in the production and distribution of biological products. It operates in two business segments: the food and beverage sales segment, which generates maximum revenue, and the production and distribution of biological products segment. Geographically, the Group operates only in Thailand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:XBIO has been successfully added to your 
